Advancing Microfluidic-based Protein Biosensor Technology for Use in Clinical Diagnostics
abstract: Demand for biosensor research applications is growing steadily. According to a new report by Frost & Sullivan, the biosensor market is expected to reach $14.42 billion by 2016. Clinical diagnostic applications continue to be the largest market for biosensors, and this demand is likely...
Other Authors: | |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/2286/R.I.9332 |
id |
ndltd-asu.edu-item-9332 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-asu.edu-item-93322018-06-22T03:01:57Z Advancing Microfluidic-based Protein Biosensor Technology for Use in Clinical Diagnostics abstract: Demand for biosensor research applications is growing steadily. According to a new report by Frost & Sullivan, the biosensor market is expected to reach $14.42 billion by 2016. Clinical diagnostic applications continue to be the largest market for biosensors, and this demand is likely to continue through 2016 and beyond. Biosensor technology for use in clinical diagnostics, however, requires translational research that moves bench science and theoretical knowledge toward marketable products. Despite the high volume of academic research to date, only a handful of biomedical devices have become viable commercial applications. Academic research must increase its focus on practical uses for biosensors. This dissertation is an example of this increased focus, and discusses work to advance microfluidic-based protein biosensor technologies for practical use in clinical diagnostics. Four areas of work are discussed: The first involved work to develop reusable/reconfigurable biosensors that are useful in applications like biochemical science and analytical chemistry that require detailed sensor calibration. This work resulted in a prototype sensor and an in-situ electrochemical surface regeneration technique that can be used to produce microfluidic-based reusable biosensors. The second area of work looked at non-specific adsorption (NSA) of biomolecules, which is a persistent challenge in conventional microfluidic biosensors. The results of this work produced design methods that reduce the NSA. The third area of work involved a novel microfluidic sensing platform that was designed to detect target biomarkers using competitive protein adsorption. This technique uses physical adsorption of proteins to a surface rather than complex and time-consuming immobilization procedures. This method enabled us to selectively detect a thyroid cancer biomarker, thyroglobulin, in a controlled-proteins cocktail and a cardiovascular biomarker, fibrinogen, in undiluted human serum. The fourth area of work involved expanding the technique to produce a unique protein identification method; Pattern-recognition. A sample mixture of proteins generates a distinctive composite pattern upon interaction with a sensing platform consisting of multiple surfaces whereby each surface consists of a distinct type of protein pre-adsorbed on the surface. The utility of the "pattern-recognition" sensing mechanism was then verified via recognition of a particular biomarker, C-reactive protein, in the cocktail sample mixture. Dissertation/Thesis Choi, Seokheun (Author) Chae, Junseok (Advisor) Tao, Nongjian (Committee member) Yu, Hongyu (Committee member) Forzani, Erica (Committee member) Arizona State University (Publisher) Biomedical Engineering Electrical Engineering Bio-MEMS Biosensors Cancer biomarkers Clinical diagnostics Microfluidics Protein sensors eng 144 pages Ph.D. Electrical Engineering 2011 Doctoral Dissertation http://hdl.handle.net/2286/R.I.9332 http://rightsstatements.org/vocab/InC/1.0/ All Rights Reserved 2011 |
collection |
NDLTD |
language |
English |
format |
Doctoral Thesis |
sources |
NDLTD |
topic |
Biomedical Engineering Electrical Engineering Bio-MEMS Biosensors Cancer biomarkers Clinical diagnostics Microfluidics Protein sensors |
spellingShingle |
Biomedical Engineering Electrical Engineering Bio-MEMS Biosensors Cancer biomarkers Clinical diagnostics Microfluidics Protein sensors Advancing Microfluidic-based Protein Biosensor Technology for Use in Clinical Diagnostics |
description |
abstract: Demand for biosensor research applications is growing steadily. According to a new report by Frost & Sullivan, the biosensor market is expected to reach $14.42 billion by 2016. Clinical diagnostic applications continue to be the largest market for biosensors, and this demand is likely to continue through 2016 and beyond. Biosensor technology for use in clinical diagnostics, however, requires translational research that moves bench science and theoretical knowledge toward marketable products. Despite the high volume of academic research to date, only a handful of biomedical devices have become viable commercial applications. Academic research must increase its focus on practical uses for biosensors. This dissertation is an example of this increased focus, and discusses work to advance microfluidic-based protein biosensor technologies for practical use in clinical diagnostics. Four areas of work are discussed: The first involved work to develop reusable/reconfigurable biosensors that are useful in applications like biochemical science and analytical chemistry that require detailed sensor calibration. This work resulted in a prototype sensor and an in-situ electrochemical surface regeneration technique that can be used to produce microfluidic-based reusable biosensors. The second area of work looked at non-specific adsorption (NSA) of biomolecules, which is a persistent challenge in conventional microfluidic biosensors. The results of this work produced design methods that reduce the NSA. The third area of work involved a novel microfluidic sensing platform that was designed to detect target biomarkers using competitive protein adsorption. This technique uses physical adsorption of proteins to a surface rather than complex and time-consuming immobilization procedures. This method enabled us to selectively detect a thyroid cancer biomarker, thyroglobulin, in a controlled-proteins cocktail and a cardiovascular biomarker, fibrinogen, in undiluted human serum. The fourth area of work involved expanding the technique to produce a unique protein identification method; Pattern-recognition. A sample mixture of proteins generates a distinctive composite pattern upon interaction with a sensing platform consisting of multiple surfaces whereby each surface consists of a distinct type of protein pre-adsorbed on the surface. The utility of the "pattern-recognition" sensing mechanism was then verified via recognition of a particular biomarker, C-reactive protein, in the cocktail sample mixture. === Dissertation/Thesis === Ph.D. Electrical Engineering 2011 |
author2 |
Choi, Seokheun (Author) |
author_facet |
Choi, Seokheun (Author) |
title |
Advancing Microfluidic-based Protein Biosensor Technology for Use in Clinical Diagnostics |
title_short |
Advancing Microfluidic-based Protein Biosensor Technology for Use in Clinical Diagnostics |
title_full |
Advancing Microfluidic-based Protein Biosensor Technology for Use in Clinical Diagnostics |
title_fullStr |
Advancing Microfluidic-based Protein Biosensor Technology for Use in Clinical Diagnostics |
title_full_unstemmed |
Advancing Microfluidic-based Protein Biosensor Technology for Use in Clinical Diagnostics |
title_sort |
advancing microfluidic-based protein biosensor technology for use in clinical diagnostics |
publishDate |
2011 |
url |
http://hdl.handle.net/2286/R.I.9332 |
_version_ |
1718699686357893120 |